wire - news in brief

« BACK

Administration



Results 1 - 50 of 195.
1 2 3 4 Next »


Administration - Careers / Employment - 20.09.2018
Facts and figures on Switzerland’s participation in the European Framework Programmes for Research
Bern, 20.09.2018 - The State Secretariat for Education, Research and Innovation (SERI) today published a report on Switzerland's involvement in the eighth European Framework Programme for Research and Innovation (Horizon 2020; 2014-2020).

Social Sciences - Administration - 06.09.2018

Medicine / Pharmacology - Administration - 29.08.2018
Alcon announces voluntary global market withdrawal of CyPass Micro-Stent for surgical glaucoma
Decision based on five-year data from COMPASS-XT long-term safety study Alcon advises ophthalmic surgeons to cease further implantation Basel, August 29, 2018 - Reflecting its uncompromising commitme

Careers / Employment - Administration - 15.08.2018

Careers / Employment - Administration - 09.08.2018
Four Million Euros Awarded to Three UZH Researchers
Three scientists of the University of Zurich have been awarded the EU's coveted ERC Starting Grants.

Medicine / Pharmacology - Administration - 27.07.2018
Novartis combination Tafinlar + Mekinist receives positive CHMP opinion for adjuvant treatment of BRAF V600 mutation-positive melanoma
Phase III trial showed a 53% reduction in risk of recurrence or death with the combination of a BRAF and MEK inhibitor as adjuvant therapy versus placebo   Relapse-free survival benefit with Tafinlar

Administration - Civil Engineering - 20.07.2018
"This is just the beginning of RESCIF's success"
The Network of Excellence in Engineering Sciences of the French-speaking Community (RESCIF), which was created at EPFL in 2011, will now be chaired by the Institut National Polytechnique Félix Houphouët-Boigny in Yamoussoukro, Côte d'Ivoire.

Administration - 28.06.2018
Ln vitro Cortical Network Firing is Homeostatically Regulated : A Model for Sleep Regulation - News
ln vitro Cortical Network Firing is Homeostatically Regulated : A Model for Sleep Regulation Sohrab Saberi-Moghadam, Alessandro Simi, Hesam Setareh, Cyril Mikhail & Mehdi Tafti Prolonged wakefulness

Administration - Medicine / Pharmacology - 30.05.2018

Administration - Careers / Employment - 15.05.2018
Competitive funding by the SNSF promotes high-quality research
Competitive funding by the SNSF promotes high-quality research
In 2017, the Swiss National Science Foundation (SNSF) invested in 2971 new projects. Each project had to undergo a stringent evaluation process in which it was rated relative to competing projects.

Administration - Innovation / Technology - 15.05.2018

Administration - 03.05.2018

Medicine / Pharmacology - Administration - 30.04.2018
Novartis receives FDA approval of Tafinlar + Mekinist for adjuvant treatment of BRAF V600-mutant melanoma
Tafinlar + Mekinist is the first oral targeted adjuvant combination therapy to demonstrate significant clinical benefit in patients with a BRAF V600 mutation, following complete surgical resection  

Medicine / Pharmacology - Administration - 16.04.2018
Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes
Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes Heart failure (HF) patients with reduced

Life Sciences - Administration - 10.04.2018
Researcher Granted EUR 2.5 Million in Funding
Each year the European Research Council (ERC), open to both junior and established researchers, awards substantial funding for outstanding fundamental research.

Innovation / Technology - Administration - 07.03.2018
Connected vehicle tech: Mandate now to save lives
ANN ARBOR-Up to 8.1 million car crashes and 44,000 deaths could be prevented if the federal government mandated connected vehicle technology now, rather than waiting even three years to develop and evaluate competing technologies.

Medicine / Pharmacology - Administration - 27.02.2018
European Commission approves Roche’s Hemlibra for people with haemophilia A with inhibitors
European Commission approves Roche's Hemlibra for people with haemophilia A with inhibitors First new medicine in over 20 years to treat people with haemophilia A with inhibitors in Europe Hemlibra d

Innovation / Technology - Administration - 27.02.2018

Medicine / Pharmacology - Administration - 13.02.2018
Sandoz announces US FDA approval and launch of Glatopa 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis
Sandoz announces US FDA approval and launch of Glatopa 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis Glatopa 40 mg/mL is a fully substitutable, AP-rated generic

Environment - Administration - 29.01.2018
Calculating the CO2 emissions of biofuels is not enough
A new EU regulation aims to shrink the environmental footprint of biofuels starting in 2021. But an EPFL scientist thinks we should go one step further and take into account all compounds produced at biorefineries, not just biofuel.

Medicine / Pharmacology - Administration - 26.01.2018
Advanced Accelerator Applications Receives FDA Approval for Lutathera for Treatment of Gastroenteropancreatic Neuroendocrine Tumors
Lutathera marks first FDA Approval for a Peptide Receptor Radionuclide Therapy (PRRT)   Advanced Accelerator Applications is a newly established subsidiary of Novartis   Lutathera expands Novartis' n

Administration - Innovation / Technology - 23.01.2018

Administration - 17.01.2018
Investigation Launched
ETH Zurich has opened an administrative investigation into allegations made against a professorship in the Department of Biosystems Science and Engineering (D-BSSE) in Basel.

Administration - Careers / Employment - 04.01.2018

Medicine / Pharmacology - Administration - 22.12.2017
Novartis’ combination therapy Tafinlar + Mekinist granted FDA Priority Review for the adjuvant treatment of stage III BRAF V600 mutation-positive melanoma
Novartis' combination therapy Tafinlar + Mekinist granted FDA Priority Review for the adjuvant treatment of stage III BRAF V600 mutation-positive melanoma Priority Review designation based on Phase I

Law / Forensics - Administration - 11.12.2017
Ontario Should Revise Discriminatory Policy Against Refugee Drivers
Allow experienced drivers from war-torn countries to skip driving-test waiting period similar to other newcomers in Ontario Toronto, ON - Ontario's Ministry of Transportation should revise its policy

Medicine / Pharmacology - Administration - 06.12.2017
Personalized Health: National Funding for Basel-led Research Groups
Personalized Health: National Funding for Basel-led Research Groups
Nine research projects involving Basel-based researchers in the field of personalized health are to receive funding from the Swiss government: support will be given to researchers from the University

Administration - Physics / Materials Science - 22.11.2017
Driving into danger with the blue lights flashing
The PSI radiation protection service is responsible for missions not only at the Institute, but throughout the canton of Aargau.

Medicine / Pharmacology - Administration - 15.11.2017
Novartis, ASCP and ACS join forces to fight cancer in Ethiopia, Uganda and Tanzania
Objective is to provide patients with rapid cancer diagnostics and appropriate care First focus will be on Ethiopia, Uganda and Tanzania Cancer is on the rise in Africa, with more than 500,000 deaths

Innovation / Technology - Administration - 15.11.2017

Medicine / Pharmacology - Administration - 11.11.2017
Punjab province in Pakistan signs agreement with Novartis Access against chronic diseases
Poor patients in Punjab will have access to high-quality  medicines against noncommunicable, chronic diseases thanks to agreement between government and Novartis Access Punjab government will make m

Medicine / Pharmacology - Administration - 01.11.2017
Roche to present new data across a range of blood diseases at the American Society of Hematology (ASH) 2017 Annual Meeting
Roche to present new data across a range of blood diseases at the American Society of Hematology (ASH) 2017 Annual Meeting Further results from emicizumab phase III studies in people with haemophilia

Administration - Astronomy / Space Science - 25.10.2017
Administrative enquiry opened
ETH Zurich is launching an administrative enquiry into allegations made in the Department of Physics.

Medicine / Pharmacology - Administration - 23.10.2017
Novartis combination adjuvant therapy Tafinlar + Mekinist receives FDA Breakthrough Therapy Designation for stage III BRAF V600 mutation-positive melanoma patients
Novartis combination adjuvant therapy Tafinlar + Mekinist receives FDA Breakthrough Therapy Designation for stage III BRAF V600 mutation-positive melanoma patients Breakthrough Therapy Designation ba

Medicine / Pharmacology - Administration - 10.10.2017

Medicine / Pharmacology - Administration - 06.10.2017
FDA approves Roche cobas Zika as first commercially-available donor screening test for Zika virus
FDA approves Roche cobas Zika as first commercially-available donor screening test for Zika virus Zika virus infection is linked to neurological complications in adults, and brain defects in fetuses

Environment - Administration - 06.10.2017
Instrument of ratification deposited: Paris climate agreement to enter into force for Switzerland on 5 November 2017
Bern, 06.10.2017 - Switzerland deposited its instrument of ratification in New York on 6 October 2017, making it an official party to the Paris Agreement.

Administration - 29.09.2017

Medicine / Pharmacology - Administration - 22.09.2017
Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries
CMLPath to Care(TM) collaboration replaces Glivec International Patient Access Program (GIPAP) with a new, independent, patient-centered access model   GIPAP was introduced 15 years ago and has provi
1 2 3 4 Next »